Tag: Ilaris

Novartis’ Ilaris first drug approved for Still’s disease

by Selina McKee | Jun 17, 2020 | News | 0

Ilaris works by blocking the effects of IL-1 and suppressing inflammation in patients with this autoinflammatory disorder

Novartis’ ‘life-changing’ Ilaris set for NHS funding

by Anna Smith | Mar 2, 2020 | News | 0

The drug is a more effective, convenient option with fewer side effects than existing treatments.

Novartis pulls EU filing for canakinumab

by Selina McKee | Dec 17, 2018 | News | 0

Novartis has pulled back its application to market canakinumab for the prevention of serious events such as stroke, myocardial infarction (MI) or death in patients who have had an MI in Europe.

Novartis bags three new approvals for Ilaris

by Selina McKee | Sep 27, 2016 | News | 0

Novartis has picked up three new indications for its anti-inflammatory Ilaris in the US, allowing its use to treat three rare and distinct types of Periodic Fever Syndromes.